Secretion of virulence factors is a critical mechanism for the establishment of cryptococcosis, a disease caused by the yeast pathogen Cryptococcus neoformans. One key virulence strategy of C. neoformans is the release of glucuronoxylomannan (GXM), a capsule-associated immune-modulatory polysaccharide that reaches the extracellular space through secretory vesicles. Golgi reassembly and stacking protein (GRASP) is required for unconventional protein secretion mechanisms in different eukaryotic cells, but its role in polysaccharide secretion is unknown. This study demonstrates that a C. neoformans functional mutant of a GRASP orthologue had attenuated virulence in an animal model of cryptococcosis, in comparison with wild-type (WT) and reconstituted cells. Mutant cells manifested altered Golgi morphology, failed to produce typical polysaccharide capsules and showed a reduced ability to secrete GXM both in vitro and during animal infection. Isolation of GXM from cultures of WT, reconstituted or mutant strains revealed that the GRASP orthologue mutant produced polysaccharides with reduced dimensions. The mutant was also more efficiently associated to and killed by macrophages than WT and reconstituted cells. These results demonstrate that GRASP, a protein involved in unconventional protein secretion, is also required for polysaccharide secretion and virulence in C. neoformans.
Introduction
Cryptococcus neoformans is a yeast-like pathogen associated with high mortality rates in immunosuppressed individuals Prado et al., 2009) . C. neoformans virulence is dependent on the expression of a number of virulence factors, including enzymes, pigments, polysaccharides and lipids (Li and Mody, 2010) . Like many bacterial pathogens, C. neoformans is surrounded by a polysaccharide capsule that is an important virulence factor (Zaragoza et al., 2009) . Capsule formation in this fungal pathogen requires intracellular polysaccharide synthesis (Feldmesser et al., 2001; Yoneda and Doering, 2006) , followed by secretion of capsular components to the extracellular space and their incorporation into the cell surface (Rodrigues et al., 2008a; Zaragoza et al., 2009 ). Capsule expression is purportedly the most important constraint for cryptococcal virulence (McClelland et al., 2005) .
Glucuronoxylomannan (GXM), the major capsular component of C. neoformans, is presumably synthesized in the Golgi and targeted to the cell surface (Yoneda and Doering, 2006) . The polysaccharide then traverses the cell wall in vesicles that reach the extracellular space (Rodrigues et al., 2007) , where GXM is used for enlargement of the cryptococcal capsule (Zaragoza et al., 2006) . Exposure of C. neoformans to brefeldin A, which affects the formation of Golgi-related transport vesicles, results in a strong inhibition of capsule assembly (Hu et al., 2007) . Consequently, the Golgi apparatus is suggested to be required for GXM synthesis and secretion, based on results of two independent studies. Yoneda and Doering demonstrated that a C. neoformans mutant lacking expression of Sav1p, a putative secretory vesicleassociated Rab GTPase essential for exocytosis, accumulates intracellular, post-Golgi vesicles containing GXM (Yoneda and Doering, 2006) . This is in agreement with results described by Panepinto and colleagues, who showed that C. neoformans cells with deficient expression of Sec6p, which mediates polarized targeting of secretory vesicles to active sites of exocytosis, had a decreased rate of GXM secretion (Panepinto et al., 2009) . Although both studies clearly indicated an association of Golgiderived pathways with GXM secretion, the fact that capsular expression was apparently normal in both sav1 and sec6 mutants suggested that other components of Golgiassociated secretory pathways could have a role in GXM traffic in C. neoformans.
Golgi reassembly and stacking proteins (GRASPs) have been implicated in the stacking of Golgi cisternae, vesicle tethering and mitotic progression (Nickel and Seedorf, 2008; Nickel and Rabouille, 2009) . GRASP is primarily attached peripherally to the cytoplasmic surface of Golgi membranes, but its distribution into other cellular compartments is also expected (Nickel and Rabouille, 2009) . In Dictyostelium discoideum, the single GRASP orthologue (GrpA) is required for unconventional secretion of acyl-coenzyme A-binding protein (AcbA) during spore differentiation (Kinseth et al., 2007) , in a process that requires secretory vesicles (Cabral et al., 2010) .
GRASP is also required for the delivery of integrin a subunits to the plasma membrane of Drosophila melanogaster in a Golgi-independent manner (Schotman et al., 2008) . More recently, it has been demonstrated GRASP is also required for starvation-induced secretion of AcbA in Saccharomyces cerevisiae and Pichia pastoris (Duran et al., 2010; Manjithaya et al., 2010) .
The fact that a number of the cryptococcal virulence factors are exocellular components (Li and Mody, 2010) implies that secretory activity is directly linked to virulence in C. neoformans. Most of the C. neoformans virulence factors are released to the extracellular space apparently through unconventional mechanisms of secretion (Rodrigues et al., 2007; 2008a,b; Nosanchuk et al., 2008; Casadevall et al., 2009) . The possible link between cryptococcal virulence and unconventional secretion led us to investigate the role of GRASP in an animal model of C. neoformans infection. Our results suggest that virulence is attenuated in a GRASP orthologue mutant of C. neoformans, which was associated with a defect in the ability of yeast cells to secrete GXM. To our knowledge, this is the first report showing a role for a GRASP orthologue in microbial virulence and in polysaccharide secretion in eukaryotic cells.
Results
The construction of the GRASP orthologue mutant strain used in this study is summarized in Fig. 1 . GRASP 5′ and A. Scheme for the construction of the mutant strain. GRASP gene was replaced with the hygromycin-resistant marker (Hyg R ) cassette (grey box). GRASP 5′ and 3′ flanks (5 GRASP and 3 GRASP respectively) were fused with Hyg R cassette by Delsgate methodology (Garcia-Pedrajas et al., 2008) . The resulting targeting vector (TV) was used for C. neoformans transformation. The wild-type locus of GRASP (WT) and the position of primers used for GRASP gene disruption are also indicated. The black bar scale corresponds to 500 base pairs (bp). 3′ flanks were fused with the hygromycin-resistant marker cassette by Delsgate methodology (Garcia-Pedrajas et al., 2008; Kmetzsch et al., 2010; . The resulting targeting vector was used for C. neoformans transformation, which was monitored by Southern hybridization and semi-quantitative RT-PCR. We identified a putative GRASP orthologue in the C. neoformans var. grubii (serotype A) genomic database (Broad Institute, Accession No. CNAG_03291.2). The 1051 bp putative GRASP has four introns and predicts a 256-amino-acid protein. GRASPs are characterized by the presence of two PDZ-like domains in the N-terminal region (Kinseth et al., 2007) . A BLAST search using the PDZ domains sequences from Rattus norvegicus GRASP revealed that these regions are also present in the C. neoformans GRASP orthologue.
Sequence comparisons revealed that the identity range for the PDZ-1 and PDZ-2 domains were 40% and 48% respectively ( Fig. 2A) .
A broad phylogenetic analysis including GRASP sequences from distinct eukaryotic organisms rendered a phylogeny tree split into two major clades (Fig. 2B ). Clade C-II encompasses the GRASPs from the majority of the fungi analysed, all belonging to the ascomycetes. Clade C-I harboured the GRASPs from the basidiomycetous fungi C. neoformans and Ustilago maydis, as well as those from mammalian (R. norvegicus), fly (D. melanogaster), worm (Caenorhabditis elegans), protist (Plasmodium falciparum) and amoeba (D. discoideum).
GRASP is primarily localized to the cytoplasmic surface of Golgi membranes, where it is apparently involved in the B. Phylogenetic analysis applying the Neighbour-Joining method including GRASP sequences from distinct eukaryotic organisms listed above. The phylogeny tree splits into two major clades. C-I and C-II represents clades I and II respectively. The bar marker indicates the genetic distance, which is proportional to the number of amino acid substitutions.
stacking of Golgi cisternae in eukaryotic cells (Vinke et al., 2011) . Based on this observation, we evaluated whether lack of GRASP would affect Golgi morphology in C. neoformans. The Golgi marker N- [7-(4-nitrobenzo-2-oxa-1,3-diazole) ]-6-aminocaproyl-D-erythro-sphingosine (C6-NBD-ceramide) stained wild-type (WT) cells producing a pattern that was very similar to that described for S. cerevisiae (Levine et al., 2000) (Fig. 3) . Mutant cells, however, showed altered Golgi morphology. In these cells, the Golgi apparatus appeared to be compacted and limited to a smaller area of the cytoplasm.
Extracellular molecules are crucial to the cryptococcal pathogenesis (Li and Mody, 2010) . Post-Golgi secretion is also involved in the release of C. neoformans virulence factors (Yoneda and Doering, 2006; Panepinto et al., 2009; Chayakulkeeree et al., 2011) . These observations and the recently described roles of GRASP in unconventional secretion (Kinseth et al., 2007; Levi and Glick, 2007; Schotman et al., 2008; Duran et al., 2010; Manjithaya et al., 2010) led us to hypothesize that Golgi integrity would be required for the pathogenic mechanisms of C. neoformans. Therefore, we evaluated some virulence determinants in the GRASP orthologue mutant in comparison with both WT and complemented cells.
The GRASP orthologue mutant showed normal growth rates at 37°C (Fig. 4A) . In an intranasal model of animal infection, this mutant caused death of all animals in 18 days (Fig. 4B) . In contrast, when animals were infected with either WT or complemented cells, 100% killing was observed within 11 and 12 days post infection respectively (P < 0.01, in comparison with mutant cells). These results revealed that the GRASP orthologue mutant had attenuated virulence in an animal model of cryptococcosis.
Since the interaction of C. neoformans with macrophages is considered to be determinant in a number fungal infections (Seider et al., 2010) , we have also evaluated whether the attenuated virulence of the GRASP orthologue mutant was related to decreased levels of association of C. neoformans with macrophages. For this purpose, we incubated phagocytes with FITC-labelled yeast cells, and measured phagocytosis in an assay where the index of fluorescence of each macrophage in flow cytometry analysis was proportional to the efficacy of the fungi-host cell interaction. Our results indicate that WT and complemented strains showed similar levels of association with murine phagocytes (Fig. 4C ). The mutant, however, was more efficiently associated to macrophages, suggesting increased phagocytic indices. Treatment of the macrophage-fungi complexes with trypan blue, which quenches the fluorescence of extracellularly associated yeast cells, resulted in a decreased of fluorescence levels corresponding to 8%, 12% and 7% for WT, mutant and reconstituted cells respectively (data not shown). The relatively high resistance of infected macrophages to lose fluorescence after exposure to trypan blue indicates that, in all systems, C. neoformans cells were internalized by the macrophages in high rates. WT and complemented cells were significantly more resistant than the GRASP orthologue mutant against the microbicidal activity of macrophages (P < 0.01). Similar experiments were performed after opsonization of yeast cells with monoclonal antibody (mAb) 18B7, which recognizes GXM (Casadevall et al., 1998 ) (data not shown). Antibody treatment did not influence phagocytosis of both WT and mutant cells (not shown), which can be linked to the high efficacy of fungal ingestion by the phagocytes after the 18 h incubation.
Pigmentation, urease activity and synthesis and release of capsular components are associated with the survival of C. neoformans during infection of host cells (reviewed in Zaragoza et al., 2009) . We therefore analysed the ability of the GRASP orthologue mutant to pigment, to produce extracellular urease activity, to secrete GXM and to form a polysaccharide capsule. Levels of pigmentation and urease activity in cultures of WT, mutant and reconstituted cells were similar (Fig. 5 ). After cultivation under regular (non-inducing) conditions of growth and capsule synthesis, the GRASP orthologue mutant manifested a hypocapsular phenotype, in comparison with WT and reconstituted cells ( Fig. 6A-C) . Fluorescence microscopy revealed that GXM was detected at the cell surface of both WT and reconstituted cells, as well as in the mutant. In the latter, some of the cells appeared to lack a detectable capsule, while other cells showed the hypocapsular phenotype as observed by India ink counterstaining.
The hypocapsular phenotype of the GRASP mutant was apparently related to a defective ability to secrete GXM, since the concentration of this major capsular component in culture supernatants of the GRASP orthologue mutant was significantly lower than in supernatants of WT and reconstituted cultures (Fig. 6D) . Analysis of infected organs revealed that the concentration of lung GXM was not significantly affected by lack of GRASP (data not shown). In the brain, however, deletion of GRASP resulted in a marked decrease in the ability of cryptococci to release GXM (Fig. 6E) .
Although secretion of capsular components is required for capsule assembly, it was recently demonstrated that capsule enlargement also requires polysaccharide molecules with higher effective diameters (Frases et al., 2009). We then analysed this parameter in GXM fractions from WT and mutant cells (Fig. 7) . Profiles of diameter distribution of GXM isolated from culture supernatants of WT and complemented cells were very similar. However, values for the effective diameter for polysaccharide fractions obtained from cultures of the mutant were below the detection limit under the conditions used in this study. Since interaction with divalent cations is known to promote GXM aggregation and to increase the dimensions of polysaccharide molecules Frases et al., 2008) we incubated the extracellular GXM samples with 1 mM CaCl 2 for 1 h to favour detection of smaller molecules. Under these conditions, extracellular GXM fractions from the GRASP orthologue mutant reached dimensions that were within the limit of detection of the method.
In the presence of CaCl2, the complemented strain and the GRASP orthologue mutant exhibited a similar pattern of GXM diameter, in contrast to the apparently ordered structures formed by WT cells. The explanation for these findings is still unclear. GXM aggregation is dependent on the availability of glucuronic acid residues, which is favoured when larger polysaccharide fractions are tested Frases et al., 2008; 2009 ). Therefore, the pattern in size observed for each sample after addition of Ca 2+ is likely influenced by the availability of glucuronic acid residues. However, this remains to be determined. In fact, properties of capsule/GXM were modified in some of the experiments in which the complemented strain was used. These modified characteristics included exacerbated GXM secretion (Fig. 6 ) and aggregation in the presence of Ca 2+ (Fig. 7) . The complemented graspD::GRASP strain used in this study was generated by ectopic integration of the WT gene in the GRASP orthologue mutant, which is likely responsible for overexpression of the GRASP-coding gene.
Discussion
Fungal cells evolved a number of unconventional secretion mechanisms to release proteins to the extracellular milieu (Albuquerque et al., 2008; Rodrigues et al., 2008b; Panepinto et al., 2009; Duran et al., 2010; Manjithaya et al., 2010; Oliveira et al., 2010a,b) . In addition to the well-characterized unconventional secretory pathways, fungi have been proposed to exploit a vesicular pathway for the trans-cell wall passage of molecules to the extracellular milieu (Albuquerque et al., 2008; Rodrigues et al., 2007; 2008a,b; Nosanchuk et al., 2008; Casadevall et al., 2009; Eisenman et al., 2009; Oliveira et al., 2009; 2010b; Vallejo et al., 2010) . The genes and cognate proteins involved in such mechanisms, however, are only partially characterized. Polysaccharides, lipids and pigments can also be extracellularly secreted by fungi (Rodrigues et al., 2007; Eisenman et al., 2009) , but the pathways required for these processes remain largely unknown. GXM biosynthesis in C. neoformans, in fact, illustrates this scenario. Many of the enzymes required for synthesis of this polysaccharide have been described (reviewed in Doering, 2009 ), but several aspects related to its cellular distribution and traffic remain unknown. Intracellular GXM is associated to the membranes of still uncharacterized organelles (Oliveira et al., 2009 ). Extracellular GXM is found either free as a soluble polysaccharide (reviewed in Zaragoza et al., 2009) , or associated to exosome-like structures (Rodrigues et al., 2007) . Defects in GXM production and capsule assembly led to avirulent phenotypes in C. neoformans (reviewed in Zaragoza et al., 2009) . Since GXM production and extracellular release are crucial for cryptococcal pathogenesis, this is clearly an area of active study.
A few examples of cryptococcal genes implicated in GXM traffic and secretion are available in the literature, including CAP59, SAV1 and SEC6. CAP59 gene produces a 458-amino-acid protein of unknown function that has identity to CMT1, whose product has a-1,3-mannosyltransferase activity (Chang et al., 1995; Sommer et al., 2003) . Deletion of CAP59 resulted in acapsular cells with increased cell body diameters (Garcia-Rivera et al., 2004) , which was attributed to intracellular polysaccharide accumulation. In fact, a missense mutation of CAP59 partially hampered the trafficking of GXM, but not of proteins (Garcia-Rivera et al., 2004) . The existence of cellular pathways required for GXM export was further confirmed in studies focused on the role of post-Golgi secretion events in C. neoformans. The products of SAV1 and SEC6 genes, which correspond to a putative vesicle-associated Rab GTPase and to a member of the post-Golgi exocytic complex, respectively, were demonstrated to be involved in vesicle-mediated export of GXM to the surface of C. neoformans (Yoneda and Doering, 2006; Panepinto et al., 2009) . GXM is then released to the extracellular space in vesicles that traverse the cell wall (Rodrigues et al., 2007) . Therefore, extracellular GXM release is linked to elements of the conventional, post-Golgi secretory pathway (Hu et al., 2007; Panepinto et al., 2009; Yoneda and Doering, 2006) and to exosome-like structures (Rodrigues et al., 2007) . Nevertheless, the involvement of other cellular pathways in the traffic of the polysaccharide is largely unknown.
In S. cerevisiae and P. pastoris, GRASP is involved in unconventional secretory mechanisms that require the participation of genes related to autophagy, early endosomal compartments and MVBs (Duran et al., 2010; Manjithaya et al., 2010) . The possibility raised by many authors that GXM secretion could involve such organelles (Takeo et al., 1973a,b; Yoneda and Doering, 2006; Albuquerque et al., 2008; Nosanchuk et al., 2008; Rodrigues et al., 2008a; Casadevall et al., 2009; Oliveira et al., 2009) combined to the emerging roles of GRASP in unconventional secretory pathways (Kinseth et al., 2007; Levi and Glick, 2007; Schotman et al., 2008; Nickel and Rabouille, 2009; Cabral et al., 2010; Duran et al., 2010) prompted us to ask whether GRASP would also regulate GXM secretion and virulence in C. neoformans.
In comparison with WT and reconstituted cells, the GRASP orthologue mutant of C. neoformans was less efficient in killing lethally infected mice and more effectively phagocytized by macrophages. A possible explanation for this finding would be its reduced ability to secrete GXM and/or to form regular capsules. Since the polysaccharide is believed to cause many deleterious effects to the host (reviewed in Zaragoza et al., 2009) , the reduction of the extracellular concentration of GXM would favour host defence resulting in infection control. Although the absence of GRASP was correlated with attenuated virulence, the C. neoformans mutant lacking this protein was still able to kill all the mice. Hence, it would be reasonable to infer that GRASP deletion generated a partial phenotype in that capsule assembly, GXM secretion and virulence were affected. This scenario, therefore, would reflect quantitative and not qualitative alterations, suggesting that other molecules in addition to GRASP may play redundant roles in polysaccharide secretion and capsule assembly. Remarkably, GXM obtained from the GRASP orthologue mutant had altered physical chemical properties (reduced dimensions), although still recognized by an antibody raised to the polysaccharide. The fact that the mutant produced smaller GXM molecules is consistent with the observation of a reduced capsule.
Capsule enlargement was demonstrated to be linked to the availability of polysaccharide molecules of increased dimensions .
Based on studies with mAbs, it is generally accepted that the first steps of GXM synthesis occur intracellularly (Feldmesser et al., 2001; Garcia-Rivera et al., 2004; Yoneda and Doering, 2006; Oliveira et al., 2009) . However, it is not known whether polysaccharide molecules distributed to intracellular organelles show the same structural features observed in extracellular fractions. For instance, antibodybinding GXM small precursors could be synthesized in intracellular compartments to be then transferred to the extracellular space, where polymerization would occur by aggregative mechanisms Frases et al., 2009) . In this case, the reduced secretion of GXM by the GRASP orthologue mutant would be simply related to impaired cellular traffic, as described for other systems (Kinseth et al., 2007; Duran et al., 2010; Manjithaya et al., 2010) . GXM polymerization would be favoured in conditions where the polysaccharide is more abundant , and this might explain why the effective diameter of GXM is reduced in supernatants of the mutant.
GRASP is required for unconventional secretion in D. discoideum, S. cerevisiae, P. pastoris and D. melanogaster (Kinseth et al., 2007; Duran et al., 2010; Manjithaya et al., 2010) . It is well accepted that GRASP is a Golgi-associated protein, which is in agreement with our current results. However, it has also been proposed that this protein could mediate vesicle fusion events at the plasma membrane (Nickel and Rabouille, 2009 ). This proposal is in agreement with the fact that GRASP is localized at the plasma membrane during epithelial cell remodelling in D. melanogaster (Schotman et al., 2008) . Remarkably, D. discoideum cells lacking GRASP show defects in the final stage of fusion of vesicles required for unconventional secretion with the plasma membrane (Cabral et al., 2010) . In contrast to what has been demonstrated for a S. cerevisiae grasp mutant (Oliveira et al., 2010b) , C. neoformans cells lacking GRASP showed normal extracellular release of vesicles (L. Sobrino, unpubl. data). This could suggest that, in C. neoformans, GRASP is required for GXM loading into secretory vesicles rather than in the release of these structures to the extracellular space, although we still do not have any evidence that GXM and GRASP interact. Alternatively, the role played by GRASP in polysaccharide traffic could be related to its presence in Golgi cisternae, which also requires experimental confirmation.
Protein secretion has been extensively explored in bacterial and eukaryotic cells. Although polysaccharide secretion in fungi was described many decades ago, the regulatory mechanisms are largely unexplored. To our knowledge, this is the first study to demonstrate a role for GRASP in polysaccharide secretion, as well as in microRole of GRASP in polysaccharide secretion 213 bial virulence. The observation that GRASP regulates a process required for the pathogenesis of C. neoformans adds a new function to the list of the important roles played by this protein in the biology of eukaryotic organisms.
Experimental procedures

Fungal strains, plasmids and media
Cryptococcus neoformans H99 strain was employed as a recipient for creating target gene deletion. Plasmid pJAF15, which contains the hygromycin marker cassette, was a generous gift of Joseph Heitman (Duke University, Durham, NC USA). Plasmid pAI4, which contains the nourseothricin marker cassette, was kindly provided by Alexander Idnurm (University of Missouri-Kansas City Kansas City, MO USA). The strains were maintained on YPD medium (1% yeast extract, 2% peptone, 2% dextrose and 1.5% agar). YPD plates containing hygromycin (200 mg ml -1 ) were used to select C. neoformans grasp deletion transformants (graspD strain). YPD plates containing nourseothricin (100 mg ml -1 ) were used to select C. neoformans grasp reconstituted transformants (graspD::GRASP strain).
In silico analysis of the C. neoformans GRASP orthologue
The putative C. neoformans GRASP gene sequence was identified by a BLAST search of the C. neoformans var. grubii strain H99 genomic database at the Broad Institute using GRASP sequences of S. cerevisiae (GenBank Accession No. NP_593015) and D. discoideum (GenBank Accession No. EAL60823). The amino acid sequences of GRASP orthologues from R. norvegicus, C. elegans, D. melanogaster, S. cerevisiae, D. discoideum, Schizosaccharomyces pombe, P. falciparum, Aspergillus nidulans, U. maydis, Candida albicans and C. neoformans were aligned using CLUSTALX2 (Larkin et al., 2007) . Mega4 were used for phylogenetic analysis applying the Neighbour-Joining method and the tree architecture was inferred from 10 000 bootstraps (Tamura et al., 2007) . The identification of the PDZ domains in the sequences was performed by BLAST search of the previous sequences with the R. norvegicus PDZ domains as previously described (Kinseth et al., 2007) .
Disruption and complementation of GRASP Disruption of GRASP was achieved employing the Delsgate methodology (Garcia-Pedrajas et al., 2008; Kmetzsch et al., 2010; . A Gateway cloning system donor vector (Invitrogen, Carlsbad, CA) containing the hygromycin selectable marker for C. neoformans transformation was constructed. A 2.2 kb PCR product spanning the hygromycin marker cassette fragment was amplified from pJAF15 and cloned into the EcoRV site of pDONR201 (Invitrogen, Carlsbad, CA). The resulting vector was named pDONRHYG. The 5′ and 3′ GRASP flanks (702 bp and 700 bp respectively) were PCRamplified and purified from agarose gels (Illustra GFX PCR DNA and Gel Band Purification kit, GE Healthcare, Buckinghamshire, UK). Approximately 300 ng of pDONRHYG and 30 ng of each PCR product were submitted to BP clonase reaction, according to manufacturer's instructions (Invitrogen, Carlsbad, CA). The product of this reaction was transformed into Escherichia coli OmniMAX 2-T1. After confirmation of the correct deletion construct, the plasmid was linearized with I-SceI prior to C. neoformans biolistic transformation (Toffaletti et al., 1993) . The mutants were screened by colony PCR, and the deletion was confirmed by Southern blot and semiquantitative RT-PCR analyses. For complementation, a 3 kb genomic PCR fragment containing the WT GRASP gene was cloned into the SmaI site of pAI4. The resulting plasmid was used for transformation of the GRASP orthologue mutant strain. Genomic insertion of the complemented gene was confirmed by Southern blot and semi-quantitative RT-PCR analyses. The primers used in these plasmid constructions are listed in Table 1 . The strategy used for generation of C. neoformans grasp mutant strain is summarized in Fig. 1 .
Staining of the Golgi apparatus
Staining of the Golgi apparatus was based on the protocols described by Pagano and colleagues (Pagano, 1989; Pagano et al., 1989) . The Golgi staining reagent was C6-NBD-ceramide, which accumulates at the Golgi apparatus of either living or fixed cells (Pagano, 1989) . C6-NBDceramide has been successfully used to stain S. cerevisiae Golgi-related structures (Levine et al., 2000) . Yeast cells were fixed with paraformaldehyde 4% in PBS, followed by washing with PBS and incubation with C6-NBD-ceramide (5 mM) for 16 h at 4°C. The cells were then incubated with fetal calf serum (10%) at 4°C for 1 h to remove the excess of C6-NBD-ceramide (Pagano, 1989) . For staining of the cell wall, the cells were then incubated for 15 min with Uvitex 2B (0.1 mg ml -1 ; Polysciences, Warrington, PA), followed by washing with PBS and analysis by fluorescence microscopy. Images were generated in an ApoTome 2 epifluorescence microscope (Carl Zeiss, Germany) and processed with the AxioVision software (Carl Zeiss, Germany).
Virulence assay
Virulence studies were conducted according to a previously described intranasal inhalation infection model (Cox et al., 2000) using eight female BALB/c mice (approximately 6 weeks old) for each strain. Mice were infected with 10 7 yeast cells suspended in 50 ml of saline and monitored daily. Animal studies were approved by the Federal University of Rio Grande do Sul Ethics Committee. Kaplan-Meier analysis of survival was performed using GraphPad Software.
Phagocytosis of C. neoformans cells by murine macrophages
Murine macrophage-like cells (RAW 264.7 lineage) were obtained from the American Type Culture Collection (ATCC). Cultures were maintained and grown to confluence in 25 cm 2 culture flasks containing Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) at 37°C and 5% CO2. The culture medium was replaced with fresh media for further incubation with fluorescein isothiocyanate (FITC, Sigma Aldrich Corp, St Louis, MO)-labelled C. neoformans yeast cells (Barbosa et al., 2006) . Fluorescent yeast cells were prepared by staining with 0.5 mg ml -1 FITC in PBS (25°C) for 10 min. FITC-labelled C. neoformans were then suspended in DMEM to generate a ratio of 10 fungal cells per macrophage for further incubation at 37°C and 5% CO2 for 18 h. In some systems, yeast cells were opsonized by treatment with mAb 18B7 (10 mg ml -1 ) for 1 h at 37°C. For negative control we used an isotypematched irrelevant IgG at the same concentrations used for mAb 18B7. Non-adherent yeast cells were removed by washing with PBS. Fungi-host cell complexes were then treated for 10 min at 25°C with trypan blue (200 mg ml -1 ) to discriminate between surface-associated and intracellular yeast cells. After removal from the plastic surface with a cell scrapper, the cells were analysed by flow cytometry as described previously (Barbosa et al., 2006) . Control preparations were developed as described above using uninfected cells and non-stained yeast. Alternatively, infected macrophages were lysed with cold water and the remaining suspension was plated onto Sabouraud solid agar for counting of colony-forming units (cfu). These values were used for calculation of the survival indices of C. neoformans after interaction with the phagocytes. The survival index was defined as the number of cfu divided by the fluorescence index of macrophages in each experimental system.
GXM and capsule determination
Cryptococcus neoformans cells (WT, mutant and reconstituted strains) were placed onto glass slides and mixed with similar volumes of India ink. The suspensions were covered with glass coverslips and analysed with an Axioplan 2 (Zeiss, Germany) microscope. Images were acquired using a Color View SX digital camera and processed with the software system analySIS (Soft Image System). Capsule sizes, defined as the distances between the cell wall and the outer border of the capsule in India ink stained yeast cells, were determined by using the ImageJ Software (version 1.33), elaborated and provided by National Institutes of Health (NIH, http://rsb.info.nih.gov/ij/). Cell diameters were determined using the same software. Final measurements were presented as ratio of capsule size/cell diameter. Cellular suspensions were analysed by fluorescence microscopy. The staining reagents used in fluorescence microscopy included calcofluor white, which has been extensively used to stain chitin in fungal cell walls, and the mAb 18B7, a mouse IgG1 with high affinity for GXM of different cryptococcal serotypes (Casadevall et al., 1998) . Yeast cells (10 6 ) were suspended in 4% paraformaldehyde cacodylate buffer (0.1 M, pH 7.2) and incubated for 30 min at room temperature. Fixed yeast cells were washed twice in PBS and incubated in 1% bovine serum albumin in PBS (PBS-BSA) for 1 h. The cells were then suspended in 100 ml of a 25 mM calcofluor white solution (Invitrogen, Carlsbad, CA) for 30 min at 37°C. After washing in PBS, the cells were incubated for 1 h in the presence of mAb 18B7 (1 mg ml -1 ). The cells were finally incubated with a fluorescein isothiocyanate (FITC)-labelled goat anti-mouse IgG (Fc-specific) antibody (Sigma Aldrich Corp, St Louis, MO). For negative control we used an isotype-matched irrelevant IgG at the same concentrations used for mAb 18B7. Cell suspensions were mounted over glass slides as described above and analysed under an Axioplan 2 (Zeiss, Germany) fluorescence microscope. Images were acquired and processed as described above.
Determination of GXM concentration in fungal supernatants and infected tissues
Culture supernatants were obtained as recently described . GXM concentration in fungal supernatants was determined by ELISA with mAb 18B7, using modifications of a previously described protocol for GXM detection (Casadevall et al., 1992; Fonseca et al., 2009) . Briefly, 96-well polystyrene plates were coated with standard GXM, supernatant samples for further blocking with bovine serum albumin. The plates were sequentially incubated with mAb 18B7 and an alkaline phosphatase-conjugated goat anti-mouse IgG1 for 1 h. Reactions were developed after the addition of p-nitrophenyl phosphate disodium hexahydrate, followed by measuring absorbance at 405 nm with a microplate reader (TP-reader, Thermo Plate). Antibody concentration in this assay corresponded to 1 mg ml -1 . For in vivo determinations, tissue samples were obtained after intranasal infection female BALB/c (n = 10) with 10 6 yeast cells of WT, mutant or reconstituted C. neoformans cells (Cox et al., 2000) . At day 7 post infection, animals were euthanized and their lungs and brains were aseptically excised. Tissues were then homogenized by maceration in PBS. These suspensions were plated on Sabouraud agar for cfu counting or were processed for GXM determination. For this purpose, suspenRole of GRASP in polysaccharide secretion 215 sions were supplemented with proteinase K (0.2 mg ml -1 , final concentration) and incubated overnight at 37°C. Samples were then heated for 20 min at 100°C, placed on ice and centrifuged at 10 000 g. Supernatants were then used in for GXM determination. For the in vivo systems, high backgrounds were observed when samples were analysed by ELISA (data not shown). We therefore analysed in vivo samples by dot blotting. Samples were loaded onto nitrocellulose membranes, which were allowed to dry for 1 h at 37°C and then were blocked with PBS containing 5% bovine serum albumin. Blocked membranes were incubated with mAb 18B7 at a starting dilution of 1 mg ml -1 . After being washed extensively, membranes were sequentially incubated with peroxidase-conjugated goat anti-mouse IgG1 and orthophenylene diamine solutions. Reactions were quantified by densitometry with the Scion Image software (version 4.03) and normalized to cfu values and weight of infected tissues.
Analysis of virulence factors
Urease activity and melanin formation, two well-defined C. neoformans virulence factors that are related to vesicular secretion (Rodrigues et al., 2008b; Eisenman et al., 2009) , were used as prototypes in assays aiming at the evaluation of virulence determinants that are not associated to capsule expression. Urease activity was assayed after growth of WT, mutant and reconstituted strains in Christensen's agar medium at 30°C for 48 h (Cox et al., 2000) . This medium contains 300 mM urea and phenol red as a pH indicator. The urease activity is expected to convert urea into ammonia, resulting in an increase in the pH of the medium. This feature is reflected by a colour change from yellow to bright pink. A ure1 mutant was used as a negative control. Analysis of melanin production followed the methodology described by Baker et al. (2007) . WT, mutant and complemented cells were inoculated in a chemically defined medium containing L-asparagine (1 g l -1 ), MgSO4·7H2O (0.5 g l -1 ), KH2PO4 (3 g l -1 ) and thiamine (1 mg l -1 ), supplemented with 10 mM L-3,4-dihydroxyphenylalanine (L-DOPA). C. neoformans cells were then cultivated at 30°C. After 24 h intervals, the cultures were centrifuged 1000 g for 10 min; pellets were photographed for visual analysis of pigmentation and the supernatants were spectrophotometrically analysed (absorbance 492 nm). Shorter times were also analysed, but pigmentation was only observed after 24 h in the culture medium (data not shown).
GXM effective diameter
For diameter determination, extracellular GXM was isolated from culture supernatants as previously described by our group . Yeast cells were cultivated in a minimal medium composed of glucose (15 mM), MgSO4 (10 mM), KH2PO4 (29.4 mM), glycine (13 mM) and thiamineHCl (3 mM), pH 5.5, for 2 days at room temperature with shaking and separated from culture supernatants by centrifugation at 4000 g (15 min, 4°C). The supernatant fluids were collected and again centrifuged at 15 000 g (15 min, 4°C), to remove smaller debris. The pellets were discarded and the resulting supernatant was concentrated approximately 20-fold using an Amicon (Millipore, Danvers, MA) ultrafiltration cell . After supernatant concentration, the viscous layer formed was collected with a cell scraper and transferred to graduated plastic tubes for GXM determinations. The effective diameter of GXM in these samples was determined by Quasi elastic light scattering in a 90Plus/BI-MAS Multi Angle Particle Sizing analyser (Brookhaven Instruments Corp., Holtsville, NY), using minor modifications of the method described by Frases et al. (2009) . Polysaccharide diameter was modulated by incubation of dialysed fractions with 1 mM CaCl2 for 1 h at room temperature.
